Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Disclosures: Dr. Sandal has received an education grant from Amgen Canada. Dr. Fiset has participated in paid consulting services or has received honoraria for participating in advisory boards with Amgen, Astellas, AstraZeneca, Bristol Meyers Squibb, EMD Serono, Incyte, Merck, Novartis, Pfizer, and Precision Rx-Dx. Dr. Samanta participated in advisory boards for Novartis, GSK, Otsuka, and receives honoraria from Alexion and AstraZeneca. The rest of the authors have no relevant disclosure.

留言 (0)

沒有登入
gif